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1. LIST OF ABBREVIATIONS 
ATP: Adenosine triphosphate 
DMSO: Dimethyl sulfoxide 
EDTA: Ethylenediaminetetraacetic acid 
EGTA: Ethylene glycol-bis(P-aminoethyl ether)-N,N,N',N'-tetraacetic acid 
FCD: Functional capillary density 
GERD: Gastroesophageal reflux disease 
HC1: Hydrochloric acid 
H&E: Hematoxylin-eosin 
LES: Lower esophageal sphincter 
MAP: Mean arterial pressure 
MC: Mast cell 
MPO: Myeloperoxidase 
NADPH: Nicotinamide adenine dinucleotide phosphate 
NF: Nuclear factor 
7-NI: 7-Nitroindazole 
NO: Nitric oxide 
NOS: Nitric oxide synthase 
cNOS: Constitutively expressed nitric oxide synthase 
eNOS: Endothelial nitric oxide synthase 
iNOS: Inducible nitric oxide synthase 
nNOS: Neuronal nitric oxide synthase 
PC: Phosphatidylcholine 
PMNG: Polymorphonuclear leukocyte 
PPE Proton pump inhibitor 
RBCV: Red blood cell velocity 
RVA: Relative vessel area 
YD: Vessel diameter 
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2. INTRODUCTION 
2.1. BACKGROUND 
Regurgitation of the gastric or duodenal content into the esophageal lumen is virtually 
an everyday phenomenon in everyone. Nevertheless, repeated regurgitation, together with the 
insufficiency of antireflux mechanisms, may lead to gastro-esophageal reflux disease 
(GERD), one of the most common gastrointestinal diseases in Europe. Recent 
epidemiological studies revealed that 10-48% of the population suffer from GERD symptoms, 
and the prevalence of GERD is likewise increasing in other parts of the world (Goh et al, 
2004, Fujiwara et al., 2005). 
The leading symptoms of the disease are heartburn, noncardiac chest pain, dysphagia 
or odynophagia. Extraesophageal symptoms include chronic cough, laryngitis, asthma, 
chronic sinusitis and dental erosions. 
The etiology of GERD is clearly multifactorial. Incompetency of the lower esophageal 
sphincter (LES), a decreased esophageal clearance, a weak esophagus body motility, 
abnormal gastric emptying and hiatal hernia are important factors. An increased 
intraabdominal pressure (e.g. obesity, obstipation, ascites or pregnancy) and medication 
which weakens the LES function (e.g. anticholinergic drugs or calcium-channel blocking 
agents) can additionally contribute to the pathogenesis of GERD. 
Prolonged regurgitation of the stomach or duodenal content can lead to different 
complications such as esophagitis, ulcer, stricture and Barret's esophagus, which predisposes 
to malignancy. Barret's esophagus is a metaplastic condition that affects the lower esophagus, 
where the normal squamous epithelium is replaced by columnar lined epithelium. This 
complication occurs in 15 to 20% of GERD patients (Hirota et al, 1999, DeMeester et al, 
2000). Indeed, the prevalence of adenocarcinoma of the esophagus and esophagogastric 
junction is increasing at an extraordinary rate (Devesa et al, 1998). 
Gastric acid has been shown to play a crucial role in the development of esophagitis 
and it was traditionally considered to be the main pathogenetic factor of GERD. 
Consequently, the cornerstone of therapy was virtually complete acid suppression through use 
of proton pump inhibiors (PPIs). However, PPI treatment has proved to be ineffective in 
several cases and esophagitis is a frequent finding even after total gastrectomy (Bremner et 
al, 1993). In recent decades, the association between esophageal inflammation and the role of 
regurgitated bile were extensively studied (Attwood et al, 1989, Miwa et al, 1996, Vaezi et 
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aL, 1996). Bile can often be detected in the esophagus, and is assumed to trigger the 
development of Barret's metaplasia and esophageal adenocarcinoma. With appropriate 
diagnostic tools (esophageal endoscopy, 24-h pH-metry or Bilitec examination), the presence 
of bile in the esophageal lumen has been proved in many cases. Accordingly, biliary or 
alkaline reflux has become a well-known and widely accepted entity in clinical practice. 
Further studies concluded that the mixed reflux of gastric and duodenal juices is more harmful 
than that of gastric acid alone (Kauer et aL, 1995). 
Although GERD is a chronic disease, critically ill or respirated patients may encounter 
an acute acidic or biliary challenge. However, regardless of the time factor, the treatment of 
alkaline esophagitis can be difficult. PPIs inhibit both gastric acidity and the secreted volume, 
but these compounds target only the gastric secretion. The efficacy of bile acid-binding agents 
is still unproven. In patients with medically refractory symptoms, conventional and minimally 
invasive surgical techniques can reduce the morbidity (Richter, 2004). Nevertheless, a non 
invasive, effective medical treatment for alkaline reflux is still not in use to date. A major 
obstacle could be that appropriate treatment or prevention of this condition requires an 
understanding of the pathogenesis of reflux-induced lesions and the nature of the 
inflammatory complications. 
Although recent experimental and clinical studies have clarified many details of the 
pathogenesis of GERD, the exact pathophysiology of the reflux-induced mucosal dysfunction 
leading to clinicopathologic complications is still unknown. As compared with an acidic 
reflux, much less information has been obtained on bile-induced inflammation. It has been 
shown that regurgitated gastric acid leads to vasodilation and increases the mucosal blood 
flow. This vasodilation is mainly due to the effect of paracrine nitric oxide (NO). Moreover, 
the histamine released from activated mast cells (MCs) increases the mucosal blood flow via a 
NO-dependent mechanism, which is considered to be an important protective reaction against 
intraluminal noxious agents (Sandler et aL, 1993, Feldman et aL, 1996). 
It has been demonstrated that bile-induced mucosal changes per se may contribute 
significantly to esophageal barrier lesions and the development of GERD (Bremner et aL, 
1993). Bile acids are responsible for the harmful effects of bile. Their cytotoxicity was first 
revealed in hepatocytes and intestinal epithelial cells. Earlier studies indicated that bile also 
plays an important role in the pathogenesis of gastritis, duodenitis and peptic ulcer. Bile acids 
may damage the mucosa in many ways. At above the critical micellar concentration in the 
extracellular space they act as a detergent and attack the lipid component of the membranes. 
Bile acids are able to enter cells due to their lipophilicity and to interfere with different cell 
functions. Several lines of indirect evidence suggest that a mitochondrial dysfunction may 
play a role in the reflux-induced esophageal mucosal responses. The hepatic mitochondria are 
one of the main targets of bile-induced hepatocyte damage, and the intracellular accumulation 
of hydrophobic bile salts during cholestasis causes hepatocyte necrosis by inducing a 
mitochondrial permeability transition (Spievy et aL, 1993, Gores et aL, 1998). It has been 
demonstrated that bile action leads to adenosine triphosphate (ATP) depletion and mucosal 
damage during reflux esophagitis (Szentpali et aL, 2001). 
Attention should be paid to the role of NO in the pathophysiology of GERD. NO is a 
significant regulator of the mucosal blood flow in the gastrointestinal tract. The production of 
NO is linked to different isoforms of the enzyme nitric oxide synthase (NOS) (McKie et aL, 
1995, Salzman 1995). The NOS system consists of three distinct isoforms: neuronal NOS 
(nNOS), inducable NOS (iNOS) and endothelial NOS (eNOS). Both eNOS and nNOS are 
constitutively expressed (eNOS), but nNOS is predominant in the gastrointestinal tract 
(Fischer et aL, 1999, Qu et aL, 1999). A relative lack of NO can activate both MCs and 
leukocytes, and MC degranulation per se can bring about leukocyte accumulation and other 
characteristics of local inflammation (Kanwar et aL, 1994, Boros 2003). These data suggest 
that nNOS-derived NO can be a significant factor of mucosal homeostasis. 
Although mixed or biliary reflux is an important health care problem, to date there are 
no effective pharmacological therapies for bile-induced esophagitis. Our previous studies and 
various other lines of evidence have suggested that phosphatidylcholine (PC) may be 
protective during this condition. Stress induces the phospolipase D-catalyzed hydrolysis of 
membrane PC. This reaction leads to the endogenous production of phosphatidic acid and 
choline. Choline is a potent anti-inflammatory agent and is actively transported into the 
epithelial cells (Kuehl et aL, 1957). Choline could form part of a defense mechanism which 
may operate in biological systems against oxido-reductive stress (Ghyczy et aL, 2003). 
Furthermore, PC is taken up by phagocytic cells and accumulates in inflamed tissue (Cleland 
et aL, 1979). In vitro studies have demonstrated that PC may protect against the membrane 
damage caused by bile salts (Martin et aL, 1981, el-Hariri et aL, 1992). Further, in vivo 
studies have revealed that choline is an essential nutrient for humans and a choline deficiency 
may result in hepatic steatosis (Zeisel et aL, 1991, Buchman et aL, 1995). PC provides 
protection against many chemical toxin-induced pathological conditions, and especially liver 
damage (Kidd, 1996). 
These data drew our attention to the possible importance of PC in bile-induced esophagitis 
and served as a guideline during design of our experiments. 
2.2. AIMS 
Our first goal was to design a large animal model of acute esophagitis in order to study the 
reactions of the esophageal mucosa exposed to different components of the refluxed material. 
Secondly, we set out to characterize the earliest indicators of inflammatory processes of the 
esophageal mucosa. With this aim, we observed mucosal microcirculatory changes by 
intravital videomicroscopy, and determined biochemical and histological markers to obtain an 
insight into the functional and structural changes accompanying reflux-induced inflammation. 
In this regard, the protocol was divided into two parts. In the first study, the major aims were: 
• to create an appropriate animal model for the examination of acute esophagitis; 
• to investigate the initial processes of acute mucosal destruction; 
• to observe and characterize the intramural changes in the mucosal microcirculation; 
• to study the roles of NO and the different NOS isoforms in acute esophagitis; 
• to study the role of MCs in the pathogenesis of reflux-induced inflammation; and 
• to compare the effects of regurgitated gastric acid and bile. 
In addition to this investigation of the pathomechanism, another objective was to outline a 
means of modulating the outcome of biliary mucosal irritation. Accordingly, in a second study 
we set out to establish whether systemic PC administration can protect the esophageal mucosa 
by acting as an anti-inflammatory agent in bile-induced esophagitis. Here, the major aim was: 
• to examine the protective role of systemic PC pretreatment during acute experimental 
gastroesophageal reflux. 
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3. MATERIALS AND METHODS 
The experiments were performed in adherence to the NIH guidelines for the use of 
experimental animals. The study was approved by the Ethical Committee for the Protection of 
Animals in Scientific Research at the University of Szeged. 
3.1. EXPERIMENTAL PROTOCOL 
The experiments were performed on inbred mongrel dogs from the Animal House of 
the University of Szeged (average weight 12±3 kg) under sodium pentobarbital anesthesia (30 
mg kg"1 i.v.). Small supplementary doses of pentobarbital were administered when necessary. 
Surgery was followed by a 30-min recovery period for cardiovascular stabilization. In the first 
study, 7 ml of isotonic saline (pH 7.4) was injected into the esophageal segment for 30 min in 
order to determine the baseline variables, including the microcirculatory parameters. After 
this period, the esophagus was filled with different test solutions (7 ml) for 3 h, while the 
microcirculatory parameters were continuously observed. At the end of the experiments, full-
thickness biopsies were taken from the esophagus for histology hematoxylin-eosin (H&E) 
staining, NOS and myeloperoxidase (MPO) activity measurements. Additional biopsies were 
obtained with the freeze-clamp technique for determination of the tissue ATP content. 
Study I: The animals were randomly allocated into one or other of the following 
groups. Group 1 (n=5) served as saline-treated control. Group 2 («=8) received canine bile 
(pH 6.5). In group 3 (n=5), the animals were treated with hydrochloric acid (HC1) (pH 2.0). 
Group 4 («=5) received bile + HC1 solution (pH 2.5). 
Study II: Cardiovascular stabilization was followed by systemic pretreatment 
protocols and 30 min later the baseline variables were determined. Thereafter, identical 
observations were performed and biopsies were taken as described above. In this study the 
sections were also stained with alcian blue-safranine O in order to visualize MCs. Animals 
were allocated into the following groups. Group 1 (n=5) was the saline-treated control group. 
Group 2 («=8) received canine bile (pH 6.5). Group 3 (n=5) was pretreated with 5 mg kg"1 7-
nitroindazole (7-NI, Sigma Chem., USA) in a 0.3 ml min"1 iv infusion 30 min before bile 
administration. 7-NI is an in vivo selective inhibitor of nNOS. In group 4 (n=5), the animals 
received 50 mg kg'1 iv PC infusion 30 min before bile treatment. A 5% PC solution (soybean 
lecithin, MW: 785, Phospholipon 90, Phospholipid GmbH, Cologne, Germany) was freshly 
prepared according to the description of the manufacturer. Briefly, the PC solution contained 
deoxycholate (2.3%), NaOH (0.24%), benzyl alcohol (0.82%) and ethanol (0.27%) in distilled 
water. The intraluminal volume was identical in all groups studied. 
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3.2. SURGICAL PREPARATION 
The surgical interventions in the first and second studies were identical (Figure 1). 
The animals were placed in a supine position on a heating pad for the maintenance of body 
temperature between 37 and 38 °C. In aseptic techniques, the left femoral artery and vein were 
cannulated for the measurement of mean arterial pressure (MAP) and for fluid and drug 
administration, respectively. All animals received a continuous infusion of Ringer's lactate at 
a rate of 10 ml kg"1 h"1 during the experiments. The esophagus was inspected by endoscopy 
(Olympus GIF-E) prior to the experiments to exclude major mucosal lesions. Following a 
collar incision, a part of the cervical esophagus with intact neurovascular connections was 
dissected free, and an approximately 8-10-cm segment of the middle portion was then 
occluded at both ends with atraumatic clips. A plastic tube (0.5 mm i.d.) was inserted distally 
into the lumen and secured with a purse-string suture for the administration of test 
compounds. The objective of the videomicroscope (Cytoscan A/R, Cytometrics, PA., USA) 
was introduced into the middle portion of the prepared esophageal segment through a small 
incision. 
Figure 1. Experimental setup 
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3.3. MEASUREMENTS 
Central venous pressure and MAP were measured continuously with Statham P23Db 
transducers and registered with a computerized data-acquisition system (Haemosys 1.17, 
Experimetria Ltd., Budapest, Hungary). Arterial blood gases were measured with an AVL 
Compact 2 blood gas analyzer (AVL Compact 2, Graz, Austria). 
3 3.1. INTRAVITAL VIDEOMICROSCOPY 
An intravital videomicroscope was used with an orthogonal polarization spectral 
imaging technique (Cytoscan A/R, Cytometrics, PA, USA) to monitor microcirculatory 
changes in the esophageal mucosa (Figure 2). This technique utilizes reflected polarized light 
at the wavelength of the isosbestic point of oxy- and deoxyhemoglobin (548 nm). Since 
polarization is preserved in reflection, only photons scattered from relatively deep inside the 
tissue contribute to the image formation. In this way, a virtual light source is created in the 
tissues, so that the vessels appear black (Groner et aL, 1999). A lOx objective was introduced 
into the esophageal lumen and was connected to a light source with a flexible cable; in this 
way, the esophageal segment was not exteriorized during the experiments. The microscopic 
images were recorded with an SVHS video recorder (Panasonic AG-TL 700). 
Videomicroscopic observations were made at specific anatomic locations at a depth of 
approximately 200 fim. Quantitative assessment of the microcirculatory parameters was 
performed off-line by frame-to-frame analysis of the videotaped images. In the first study, the 
functional capillary density (FCD; the length of perfused nutritive capillaries per observation 
area; /mf !), the relative vessel area (RVA; the perfused vessel area per observation area), and 
the red blood cell velocity (RBCV; /urn s"1) were determined in 3 separate fields by means of a 
computer-assisted image analysis system (IVM Pictron, Budapest, Hungary). In the second 
study, the RBCV and vessel diameter (VD, fivsx) changes in the postcapillary venules were 
determined. Changes in venular wall diameter were determined by following identifiable 
visual landmarks within the vessel wall. All microcirculatory evaluations were performed by 
one investigator (GE). 
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Figure 2. The Cytoscan A/R videomicroscope (Cytometrics, USA) 
3.3.2. NO SYNTHASE ACTIVITY MEASUREMENTS 
NO formation in esophageal tissue was measured by the conversion of [3H]L-citrulline 
from [3H]L-arginine according to the method of Szabo et al. (1993). Briefly, tissue biopsies 
kept on ice were homogenized in phosphate buffer (pH 7.4) containing 50 mM tris-
(hydroxymethyl) aminomethane-HCl (Reanal, Budapest, Hungary), 0.1 mM 
ethylenediaminetetraacetic acid (Serva Feinbiochemica GmbH, Heidelberg, Germany), 0.5 
mM dithiotreitol, 1 mM phenylmethylsulfonyl fluoride and 10 jug ml"1 soybean trypsin 
inhibitor. The homogenate was centrifuged at 4 °C for 20 min at 24 000 g and the supernatant 
was loaded into centrifugal concentrator tubes (Amicon Centricon-100; 100 000 MW cut-off 
ultrafilter). The tubes were centrifuged at 1000 g for 150 min and the concentrated 
supernatant was washed out from the ultrafilter with 300 ¡A of homogenizing buffer. The 
samples were incubated with cation-exchange resin (DOWEX AG 500W-X8, Na+ form) for 5 
min to deplete endogenous L-arginine. The resin was separated by centrifugation (1500 g for 
10 min) and the supernatant containing the enzyme was assayed for NOS activity. 
For the Ca2+-dependent NOS (cNOS) activity, 50 ¡u\ of enzyme extract and 100 ¡A of 
reaction mixture (pH 7.4, containing 50 mM Tris-HCl buffer, 1 mM beta-nicotinamide 
adenine dinucleotide phosphate (NADPH), 10 pM tetrahydrobiopterin, 1.5 mM CaCl2, 100 U 
ml"1 calmodulin and 0.5 pCi [3H]L-arginine (ICN Biomedicals, specific activity 39 Ci mmol" 
') were incubated together for 30 min at 37 °C. The reaction was stopped by the addition of 1 
ml of ice-cold HEPES buffer (pH 5.5) containing 2 mM EGTA and 2 mM EDTA. 
Measurements were performed with boiled enzyme and with the NOS inhibitor N-ro-nitro-L-
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arginine (3.2 raM) to determine the extent of [3H]L-citruliine formation independent of the 
NOS activity. Ca2+-independent NOS activity (iNOS) was measured without Ca-calmodulin 
and with EGTA (8 mM). 
1 ml reaction mixture was applied to DOWEX cation-exchange resin (AG 50WX8, 
Na+ form) and eluted with 2 ml of distilled water. The eluted [3H]L-citrulline activity was 
measured with a scintillation counter (Tri-Carb Liquid Scintillation Analyzer 
2100TR/2300TR, Packard Instrument Co, Meriden, CT, U.S.A.). Protein contents of samples 
were determined by the method of Lowry et aL (1951). 
3.3.3. MYELOPEROXIDASE ACTIVITY 
The activity of MPO, a marker of tissue leukocyte infiltration, was measured in 
mucosal biopsies by the method of Kuebler et aL (1996). Briefly, the tissue was 
homogenized with Tris-HCl buffer (0.1 M, pH 7.4) containing 0.1 mM polymethylsulfonyl 
fluoride to block tissue proteases, and then centrifuged at 4 °C for 20 min at 2000 g. During 
the measurements, 0.15 ml of 3,3',5,5'- tetramethylbenzidine (dissolved in DMSO; 1.6 mM) 
and 0.75 ml of hydrogen peroxide (dissolved in K3P04 buffer; 0.6 mM) were added to 0.1 ml 
samples. The reaction causes the hydrogen peroxide-dependent oxidation of 
tetramethylbenzidine, which can be detected spectrophotometrically at 450 nm (UV-1601 
spectrophotometer, Shimadzu, Japan). The MPO activities of the samples were measured at 
37 °C; the reaction was stopped after 5 min with 0.2 ml of H2S04 (2 M) and the data were 
referred to the protein content. 
3.3.4. ATP MEASUREMENT 
A whole-thickness sample was taken from the esophagus with a Wollenberg forceps 
cooled in liquid nitrogen, and the tissue was stored at -70 °C. The sample was weighed, placed 
into a 3-fold volume of trichloracetic acid (6% w/v), homogenized for 1 min, and centrifuged 
at 5000 g. The supernatant was neutralized with saturated potassium carbonate solution. The 
ATP concentration was measured spectrophotometrically according to Lamprech et aL 
(1976). The method is based on the principle that ATP is used up in an enzymatic reaction 
catalyzed by glucose-6-phosphate dehydrogenase and hexokinase. 
3.3.5. HISTOLOGY AND LIGHT MICROSCOPY 
Biopsies for light microscopy were obtained from the intact and the treated part of the 
esophagus of each animal. The samples were fixed in 10% phosphate-buffered formalin 
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solution for 24 h, embedded in paraffin, sectioned (6 jum) and stained with H&E. Histological 
analysis was performed in coded sections by one investigator. In the first part of the study, 
mucosal injury was graded on the 0-100 esophageal mucosal damage score of Lanas et aL 
(1999) with the following criteria: epithelial changes (epithelial splitting, erosion and 
ulceration): maximal score 40; inflammation (intraepithelial leukocytes and cellular 
hyperplasia): maximal score 40; vascular lesions (edema, congestion and hemorrhage): 
maximal score 20. In parallel, the degree of damage was evaluated with the 0-16 scoring 
system of Geisinger et aL (1990): basal cell hyperplasia: maximal score 4; intraepithelial 
leukocytes: maximal score 4; subepithelial leukocytes: maximal score 4; presence of 
ulceration: maximal score 4. 
In the second study, polymorphonuclear leukocytes (PMNGs) were counted in coded 
sections by two independent investigators. Five nonoverlapping fields were observed in each 
section, and in each field an average of 4 consecutive measurements were used to calculate 
the average PMN count with a semiquantitative scoring system. PMN counts were determined 
in the epithelium, submucosa, muscle layer and adventitia with the following criteria: grade 0, 
no PMNs in the given structure; grade 1, 1-10 PMNs; grade 2, 11-100 PMNs; grade 3, >100 
PMNs. 
For histology for MC reactions, esophageal biopsy samples were rapidly placed into 
ice-cold Carney's fixative, embedded in paraffin and sectioned. The sections were stained 
with acidic toluidine blue (pH 0.5) and alcian blue-safranine O (Sigma Chem. USA, pH 0.4). 
Positively stained MCs were quantified in 10 fields. The counting was performed in coded 
sections at an optical magnification of x 400 by two independent investigators. Loss of 
intracellular granules and stained material dispersed diffusely within the lamina propria were 
taken as evidence of MC degranulation. For each animal, 5 fields were chosen at random, and 
the numbers of degranulated and intact MCs were counted. All counts were pooled for each 
treatment and the percentage of degranulated MCs was calculated. 
3.3.6. STATISTICAL ANALYSIS 
Data analysis was performed with a statistical software package (SigmaStat for 
Windows, Jandel Scientific, Erkrath, Germany). Nonparametric methods were used. Friedman 
repeated measures analysis of variance on ranks was applied within the groups. Time-
dependent differences from the baseline were assessed by Dunn's method. Differences 
between groups were analyzed with Kruskal-Wallis one-way analysis of variance on ranks, 
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followed by Dunn's method for pairwise multiple comparison. In the Figures, median values 
and 75th and 25th percentiles are given. /><0.05 was considered statistically significant. 
4. RESULTS 
4.1. STUDY I 
The baseline values of the macrohemodynamic variables did not differ significantly 
in the different groups and there were no significant hemodynamic changes as compared 
with the control values during the experimental period (data not shown). In the control 
group, saline administration did not significantly influence the histology scores of the 
mucosal morphology. 
The baseline level of the capillary RBCV in the various groups ranged between 430 
and 470 pm s"1. In the control group, the RBCV in the capillaries of the esophagus did not 
change during the experiments. However, the RBCV was increased significantly after the 3-h 
exposure to the bile or HCl-containing test solutions and average values of 607, 730 and 620 
pm s"1 were measured after bile, HC1 and bile + HC1 treatment, respectively (Figure 3). 
RBCV (pm s 1) 
—a— Saline 
—o— HCI 
— B i l e x * 
700 -
X 
6 0 0 - * 
500 -
400 -
300 
0 30 60 90 120 
Time (min) 
150 180 
Figure 3. Effects of various intraluminar treatments on the red blood cell velocity (RBCV) 
of the esophageal mucosa (urn s"1). Saline treatment (thin lines with filled triangles), bile 
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treatment (thick line with empty triangles), HC1 treatment (thin line with empty squares) 
and bile + HC1 treatment (thick line with empty circles). *: p<0.05 within groups vs, 
baseline values; X: p<0.05 between groups vs, saline-treated control group values. 
The RVA was significantly elevated in all treated groups as compared with the 
sham-operated group or with the baseline. Administration of bile, HC1 alone or bile + HC1 
resulted in a rise from the baseline values of 0.319, 0.333 and 0.312 to 0.437 (0.365; 
0.473), 0.41 (0.391; 0.442) and 0.425 (0.415; 0.465), respectively (Figure 4). 
RVA 
Time (min) 
Figure 4. Changes in the relative vessel area (RVA) in the saline-treated (thin line with 
filled triangles), bile-treated (thick line with empty triangles), HC1 treated (thin line with 
empty squares) and bile + HCl-treated (thick line with empty circles) groups. *: p<0.05 
within groups vs, baseline values; X: p<0.05 between groups vs, saline-treated control 
group values. 
The FCD was not influenced by luminal bile or HC1 + bile treatment for 3 h. 
Flowever, HC1 treatment alone was followed by a significant decrease, from 0.0377 p m ] 
(0.0342; 0.040) to 0.0292 /urn1 (0.027; 0.0307) at the end of the experimental period 
(Figure 5). 
17 
FCD Oim1) 
Time (min) 
Figure 5. Changes in the functional capillary density (FCD) values (/an"1) in the saline-
treated (thin line with filled triangles), bile-treated (thick line with empty triangles), HC1-
treated (thin line with empty squares) and bile + HCl-treated (thick line with empty circles) 
groups. *: p<0.05 within groups vs baseline values; X: /?<0.05 between groups vs saline-
treated control group values. 
The effects of bile, HC1 and bile + HC1 on the mucosal morphology are presented in Figure 
6. The structural damage to the mucosa was quantified by histology, using two different 
scoring systems; in consequence of the highly characteristic tissue lesions, there was no 
significant difference between the results of the evaluation methods. The biopsy samples from 
the saline-treated control group exhibited an average grade of injury of 2.25 (range of scores: 
0-18) on the Lanas scale, and of 0.37 (range of scores: 0-3) on the Geisinger scale. The 3-h 
bile exposure induced severe mucosal damage, with median values of 65 (range: 50-70) on 
the Lanas scale, and 12 (range 8-14) on the Geisinger scale (p<0.01). Deep lesions were 
commonly observed, with extensive epithelial loss, desquamation and necrosis, intraepithelial 
and subepithelial leukocytosis, basal cell hyperplasia and subepithelial connective tissue 
damage. In most cases, transmural inflammation, edema and vasodilatation were apparent. 
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In the HCl-treated group 3, the reactive mucosal changes were different from those 
observed in the bile-treated groups. HC1 administration induced severe epithelial damage 
with considerable basal cell hyperplasia. Petechiae and deep transmural lesions were 
observed only occasionally. The median value of the Lanas scores was 30 (range 19-40), 
and that of the Geisinger scores was 5.0 (range 3-7). Following treatment with bile + HC1, 
the histology revealed less severe (mild to moderate) morphological changes. Although 
disruption of the epithelial layer, desquamation, intra- and subepithelial inflammatory cells 
and subepithelial connective tissue edema were generally observed, the deeper tissue layers 
were less involved. The degree of injury was 33 (range: 25-50) on the Lanas scale, and 5 
(range: 5-6) on the Geisinger scale. 
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Figure 6. Scores of histological evaluation of the mucosal damage of the esophagus, with 
grading performed according to Lanas et al. and Geisinger et al. (see Methods for 
description). Geisinger score: empty column; Lanas score: shaded column. The plots 
demonstrate the median (horizontal line in the box) and the 25th (lower whisker) and 75th 
(upper whisker) percentiles, respectively. X: /?<0.05 between groups vs, saline-treated 
control group values. 
The MPO data demonstrated that the leukocyte accumulation was significantly increased 
in the mucosa in groups 2, 3 and 4 as compared with the saline-treated group 1 (Figure 7). 
Bile, HCI alone or bile + HCI administration resulted in a 10-fold (M= 50.0; 25/?=29.5; 
19 
75/7=76.1), 3-fold (M=15.0; 25/7=11.2; 75/7=17.9) and 8-fold (M=41.5; 25/7=34.3; 75/7=49.9) 
rise in MPO activity, respectively. Although the average MPO values were usually higher 
within the muscle, the MPO activities in the two tissue layers were not significantly different. 
Both bile and bile + HC1 administration resulted in a 5-fold elevation, while HC1 
administration alone resulted in an approximately 2-fold increase in muscle MPO activity 
(Figure 7). 
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Figure 7. Myeloperoxidase (MPO) activity in the mucosa (empty column) and the muscle 
tissue (shaded column) of the esophagus 180 min after treatment. The plots demonstrate the 
median (horizontal line in the box) and the 25th (lower whisker) and 75th (upper whisker) 
percentiles, respectively. X: p<0.05 between groups vs saline-treated control group values. 
Figure 8 depicts the changes in the esophageal cNOS and iNOS activities. The activity 
of cNOS was significantly depressed after bile treatment, and this change was accompanied 
by a significant, approximately 6-fold increase in iNOS activity. HC1 treatment did not 
influence the esophageal cNOS activity, while it resulted in a somewhat lower, 2.5-fold 
increase in iNOS activity as compared with the value for the sham-operated group. Similarly, 
the cNOS activity was not influenced by bile + HC1 administration for 3 h, whereas the 
activity of iNOS was increased significantly, similarly as observed after bile treatment alone. 
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Figure 8. Changes in constitutive (empty column) and inducible (shaded column) NOS 
activities (fmol (mg protein"1 min"1) in esophageal tissue from saline-treated (n=5), bile-
treated («=8), HCl-treated («=5) and bile + HC1 treated (n=5) animals. The plots demonstrate 
the median (horizontal line in the box) and the 25th (lower whisker) and 75th (upper whisker) 
percentiles, respectively. X: p<0.05 between groups vs saline-treated control group values. 
4.2. STUDY II 
The baseline values of the macrohemodynamic variables did not differ significantly in 
the different groups and there were no significant hemodynamic changes as compared with 
the control values during the experimental period. The MAP in the bile+7-NI or PC-treated 
groups was not significantly different (p>0.05) from that for the saline-treated group as a 
whole. 
The baseline RBCV level in the various groups ranged between 560 and 680 /um s"1, 
and in the control group the RBCV did not change during the experiments. However, the 
RBCV was increased significantly after the 3-h exposure to bile with or without 7-NI or PC 
pretreatment. The median values were 813, 886 and 787 /um s"1 after bile, after bile with 7-NI, 
and after bile with PC pretreatment, respectively (Figure 9). 
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Figure 9. Effects of different intraluminar treatments and systemic pretreatments on the 
red blood cell velocity (RBCV; pm s"1). Saline treatment (thin line with empty circles), bile 
treatment alone (thick line with empty squares), bile treatment with PC pretreatment (thick 
line with empty triangles) and bile treatment with 7-NI pretreatment (thin line with full 
triangles) groups. *: p<0.05 within groups vs baseline values; X: p<0.05 between groups vs 
saline-treated control group values. 
Venules 35±10 pm in diameter were the largest fraction of the vessels; arterioles 
were seen only very rarely. The inner boundary of the venular wall was easily 
distinguishable and an exact comparison of inner diameter changes was possible. The 
median VD was significantly higher in the bile-treated group as compared with the saline-
treated control, and increased from the baseline value of 33 pm to 44 pm. Administration 
of 7-NI before bile treatment prevented this increase. PC pretreatment resulted in a 
significant VD elevation as compared with the control group, but the VD changes in this 
group were significantly lower than those in the bile-treated group (Figure 10). 
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Figure 10. Changes in vessel diameter (VD; pm). Saline treated (thin line with empty 
circles), bile-treated (thick line with empty squares), bile + PC-treated (thick line with 
empty triangles) and bile + 7-NI-treated (thin line with full triangles) groups. *: p<0.05 
within groups vs baseline values; X: p<0.05 between groups vs saline-treated control group 
values. 
The in vivo interference of the bile treatment with the ATP production of the 
esophageal mucosa was evaluated (Figure 11). There were no significant differences in 
tissue ATP levels between the intact and treated parts of the esophagus in the saline-treated 
control group (data not shown). There was a statistically significant, 45% fall in the ATP 
content of the esophageal tissue after bile treatment (saline: M= 4.43 pmo\ mg protein"1; 
25/7=4.21; 75/7=4.76; bile: M=2.42 pmol mg protein"1; 25/7=1.66; 75/7=2.61) by the end of 
the observation period, and this change was not affected by 7-NI treatment. Following PC 
treatment, the ATP content was significantly maintained in the mucosa as compared with 
bile treatment alone (M= 3.82; 25/7=3.56; 75/7=4.28), and this value was not significantly 
different from the corresponding value for the saline-treated group. 
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Figure 11. Effects of bile (black box), PC + bile (gray box) and 7-NI + bile (checked box) on 
the ATP content of the esophageal mucosa. The plots demonstrate the median (horizontal line 
in the box) and the 25th (lower whisker) and 75th (upper whisker) percentiles, respectively. X: 
p<0.05 between groups vs saline-treated control group values, #: p<0.05 between bile + 7-NI-
treated and bile + PC-treated groups vs bile-treated group values. 
Figure 12 demonstrates the changes in the esophageal cNOS and iNOS activities. The 
activity of cNOS was significantly depressed after bile treatment, and this change was 
accompanied by a significant, 6-fold increase in iNOS activity. The cNOS activity was not 
altered by PC or 7-NI pretreatment. However, the esophageal iNOS activity was significantly 
lower after PC pretreatment as compared with bile treatment alone. 7-NI treatment resulted in 
a somewhat lower, 2.6-fold increase in iNOS activity as compared with the value for the bile-
treated group. 
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Figure 12. Changes in constitutive (left panel) and inducible NOS (right panel) activities 
(fmol (mg protein)"1 min"1) in esophageal tissue from saline-treated (empty box), bile-treated 
(black box), bile + PC-treated (gray box) and bile + 7-NI-treated (checked box) animals. The 
plots demonstrate the median (horizontal line in the box) and the 25th (lower whisker) and 75th 
(upper whisker) percentiles, respectively. X: p<0.05 between groups vs saline-treated control 
group values, #: p<0.05 between bile + 7-NI-treated and bile + PC-treated groups vs bile-
treated group values. 
The MPO data demonstrated that the leukocyte accumulation was significantly 
increased in the mucosa in the bile-treated and 7-NI-pretreated groups as compared with the 
saline-treated group (Figure 13). Bile alone resulted in a 2.5-fold (M=209.4; 25/?=136.6; 
75/>=259.6) rise in MPO activity, and a further increase was observed after 7-NI + bile 
administration (M=315.4; 25/7=182.4; 75/7=441.8). PC pretreatment significantly decreased 
the bile-induced MPO activity. 
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Figure 13. Myeloperoxidase (MPO) activity in the esophageal mucosa 180 min after 
treatment. The plots demonstrate the median (horizontal line in the box) and the 25th (lower 
whisker) and 75,h (upper whisker) percentiles, respectively. X: p<0.05 between groups vs 
saline-treated control group values, #: p<0.05 between bile + 7-NI-treated and bile + PC-
treated groups vs bile-treated group values. 
Histological scoring of leukocyte infiltration was performed by two independent 
viewers (the inter-observer variation was less than 15%, and these data showed a good 
correlation with the MPO results). In the saline-treated group, the extravasation of PMNs was 
negligible (range of scores: 1-3; M= 2). Exposure to bile resulted in a significant (p<0.05) 
accumulation of PMNs (range: 4-6; M= 5). In the PC-pretreated animals, the PMN infiltration 
was significantly decreased and the scores not differ significantly from the control values 
(range: 1-3; M= 3). Bile + 7-NI treatment increased the degree of PMN infiltration and 
resulted in a grade 7 score (range: 7-9) (Figure 14). 
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Figure 14. Scores of leukocyte infiltration of esophageal tissue after different intraluminar 
treatments and systemic pretreatments with grading according to our scoring system (for a 
description, see the Methods). The plots demonstrate the median (horizontal line in the box) 
and the 25th (lower whisker) and 75lh (upper whisker) percentiles, respectively. X: /K0.05 
between groups v.v saline-treated control group values, #: p<0.05 between bile + 7-NI-treated 
and bile + PC-treated groups vs,bile-treated group values. 
The effects of bile and various pretreatments on the mucosal MC degranulation are 
presented in Figure 15. In the control group, 35% of the MCs had degranulated. Exposure to 
bile resulted in a significant, degranulation (M= 79.6%; 25/?=75.0; 75/7=84.6) relative to the 
control group. In the PC-pretreated group, the percentage of degranulated MCs (A/=54.3%, 
25/7=42.2%; 75/7=66.7%) proved to be significantly lower than that after bile treatment alone. 
The nNOS inhibition evoked a marked stimulation of MC degranulation over that due to bile 
treatment alone. In the 7-NI + bile-treated group, the degranulation of the mucosal MCs was 
nearly complete (M= 87.5%; 25/7=65.6%; 75/7=95.6%). 
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Figure 15. Mast cell degranulation (%) in the mucosa of the esophagus 180 min after 
treatment. The plots demonstrate the median (horizontal line in the box) and the 25th (lower 
whisker) and 75lh (upper whisker) percentiles. /?<0.05 between groups vs saline-treated control 
group values. p<0.05 between bile + 7-NI-treated and bile + PC-treated groups vs bile-treated 
group values. 
The biopsy samples from the saline-treated control group exhibited an average grade 
of injury of 5 (range of scores: 0-20) on the Lanas scale. In these sections, the luminal surface 
was always lined by a continuous layer of epithelial cells, while the vessels usually presented 
with empty lumina (Figure 16 A). The 180-min bile exposure induced significant mucosal 
damage (p<0.01), with a median value of 58 (range: 50-70). Deep lesions were observed, with 
disruption and desquamation of the epithelial layer (Figure 16B,C). Extensive intraepithelial 
and subepithelial leukocytosis and connective tissue damage were general characteristics. 
Submucosal edema, hemorrhage and vasodilatation were apparent. Semiquantitative 
evaluation of the samples from the 7-NI + bile-treated animals revealed a significant 
exacerbation of the mucosal injury (p<0.01) and an injury score of 68 (range 60-90). A 
tendency toward more intense injury was always manifested. Severe epithelial damage and 
exfoliation of the surface epithelium were present, and the deeper tissue layers were more 
strongly involved in a generalized inflammatory reaction. In most cases, transmural 
inflammatory infiltrations, vasodilation and subepithelial connective tissue edema were 
Mast cell degranulation 
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observed (Figure 16D). 
Administration of PC did not significantly influence the superficial tissue damage, but 
the reactive mucosal changes were different from those observed in the bile-treated group. In 
general, the degree of epithelial damage and the nature of the reactive epithelial changes were 
similar to those observed in the bile-treated group 2, but there was no evidence of severe 
subepithelial inflammation. The submucosal damage was often patchy; mild and severe 
lesions were commonly observed within the same section and hemorrhage was rarely 
observed. The general image of the tissue damage was somewhat improved, but this group 
had a median grade of injury of 50 (range: 40-75), a value statistically not significantly 
different (p>0.01) from the corresponding value for the bile-treated group. 
Figure 16. Photomicrographs of the esophageal wall from groups 1-4 (H&E staining). (A) 
control group (saline treatment, original magnification x 224); (B) bile treatment (epithelial 
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damage and subepithelial edema, original magnification x 112); (C) bile-treated group 
(significant leukocyte infiltration in the muscle layers and adventitia, original magnification 
xll2); (D) bile+7-NI treatment (extreme leukocyte infiltration in the adventitia, original 
magnification x224); and (E) bile + PC treatment (no significant change in the esophageal 
wall, original magnification x56; the arrow in the right upper corner shows the muscle layer 
of the same field (original magnification x400); the interstitial capillaries are filled with 
PMNs, but only a few extravasated PMNs are present). 
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5. DISCUSSION 
GERD is the most frequent inflammatory disorder of the foregut. During recent 
decades, the importance of this disease has increased steadily, and it now influences a high 
percentage of the population, with negative effects on the health-related quality of life. GERD 
is also a risk factor for Barret's esophagus and esophageal adenocarcinoma formation. 
Chronic exposure to the duodenogastric content frequently leads to an esophageal dysfunction 
and tissue damage, but an acute reflux may likewise result in severe esophagitis and 
esophageal ulceration in critically ill, mechanically ventilated patients. 
A number of studies have emphasized the impact of duodenal components in the 
progression of GERD, and duodenogastroesophageal or alkaline reflux has become an 
autonomic entity (Vaezi et al, 2001). At first sight, a biliary reflux alone can not evolve in 
GERD patients, because it is obviously associated with acidic regurgitation. However, HC1 
secretion can be completely blocked by PPI therapy. Gastric acid-suppressive therapy or 
achlorhydria may lead to bacterial colonization in the upper gastrointestinal tract (Drasar et 
al, 1969). As a result of the bacterial flora, deconjugated bile acids appear in a higher 
proportion, including severe mucosal damage in the esophagus (Salo et al, 1983). Thus, in 
patients on PPI therapy with bile regurgitation, a "bile danger zone" of higher pH (pH>5.0) 
has to be considered. These findings underline that pH-metry alone, which was earlier thought 
to be a reliable diagnostic method, is not able to prove the presence of GERD in every case. 
The significance of biliary reflux and the need for appropriate medical treatment is 
indisputable. Accordingly, the first step should be a comprehensive investigation of the 
pathomechanism to trace the possible targets of therapy. 
In the first part of our in vivo study, the separate responses to HC1 and bile were 
compared. The early microcirculatory consequences of acidic and biliary exposure were quite 
similar. It was recognized that microcirculatory changes can be considered to be parts of the 
local inflammation, and the symptoms are not influenced by macrohemodynamic variables. 
These microcirculatory changes appeared quickly as the RBCV and RVA were significantly 
increased 90 min after the start of the treatment. The RBCV is determined primarily by the 
blood flow and the cross-section of the circulatory area, and this suggests that significant 
vasodilation evolves in the mucosa. The elevated RVA values provided direct evidence of the 
presence of vasodilation. 
The results of biochemical measurements may explain the microvascular changes. 
Exposure to either HC1 or bile was accompanied by a significant rise in tissue MPO activity. 
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This phenomen is a good marker of leukocyte accumulation. The contact of the neutrophilic 
leukocyte with a chemoattractant triggers a complex metabolic event, with the production of 
oxygen intermediates. Moreover, a variety of inflammatory mediators could be released from 
these cells. Once the leukocytes have entered the tissues, they may induce further mucosal 
and submucosal damage, thereby mediating the aggressive action of intraluminal agents. 
These data suggest that leukocyte activation and tissue accumulation are important 
components of mucosal destruction in both biliary and acidic reflux. 
Comparison of the structural changes caused by the observed agents revealed 
differences between bile- and acid-induced inflammation. Severe tissue damage was 
characteristic for both groups, but exposure to bile resulted in more serious mucosal and 
submucosal injuries. In this regard, the histological results required a further explanation in 
order to allow an understanding of the difference in the pathomechanisms and to acquire valid 
conclusions from studies involving tissue salvage therapies. 
The toxicity of bile acids has already been demonstrated in hepatic tissue. It has also 
been confirmed that the intrahepatic accumulation of bile salts is directly connected with a 
mitochondrial dysfunction (Schmucker et aL, 1990, Krahenbuhl et aL, 1994). Bile salts may 
cause hepatocyte death by inducing mitochondrial permeability transition, Fas-dependent 
hepatocyte apoptosis or necrosis. Bile salts at low concentrations inhibit the activities of 
complexes I and III of the mitochondrial respiratory chain (Rosser et aL, 1995). It has been 
proved that bile, with or without gastric acid, leads to ATP depletion in esophageal tissue. A 
recent study concluded that ATP depletion of the canine esophagus after biliary exposure may 
be a result of a dramatic transcriptional level downregulation of mucosal and smooth muscle 
|3ATPase gene expression (Szentpdii et aL, 2005). However, this change was not observed 
when the esophagus was exposed to HC1 alone (Szentp&Ii et aL, 2001). In line with these 
data, a possible reason for the described morphological differences was found. These findings 
emphasize the importance of monitoring of other functional parameters. 
In the relevant literature a number of data underline the role of NO. This molecule is 
formed in vivo by the continuously active cNOS, and is involved in the physiological 
regulation of the peripheral vascular tone (Moncada et aL, 1991). In inflammation, 
endotoxemia or sepsis, a distinct form, the inducible, Ca2+-independent iNOS, is activated, 
thereby leading to an excessive production of NO (Zhang et aL 1998). NO plays a central 
role in the maintenance of the normal resting esophageal mucosal blood flow, and an 
increased esophageal blood flow may have a protective role against damaging gastric juice or 
other noxious stimuli (Sandler et aL, 1993, McKie et aL, 1995). In our study, the bile-
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induced microcirculatory alterations were accompanied by inverse changes in the cNOS and 
iNOS activities. Although gastric acid alone also increased the activity of iNOS, it did not 
influence the cNOS activity. This finding suggests that the activation of iNOS is a 
consequence of an inflammatory reaction in cases of acidic reflux. The effect of bile on NO 
production seems to be much more complex. The connection between bile and the cNOS 
activity has been described in biliary fibrosis and after experimental bile-duct ligation 
(Zimmermann et aL, 1996, Rockey et aL, 1998, Wei et aL, 2002). It has also been reported 
that a low cNOS and an increased iNOS activity are responsible for the exacerbation of 
gastric injury from luminal irritants during endotoxemia (Helmer et aL, 2002). Accordingly, 
we can presume that the higher iNOS activity is a compensatory event of cNOS inhibition, or 
an aftermath of inflammatory stimuli. Moreover, it has been described that the expression of 
iNOS is increased in taurocholate-induced pancreatitis (Satoh et aL, 1998). Although the 
lowered ATP generation could be an important factor in the acute decrease in cNOS activity, 
the intracellular biochemical mechanisms that mediate this injury are not completely 
understood. It has been speculated that unconjugated di- and trihydroxy bile acids cause 
damage by binding to and across cell membranes to enter cells. However, it has recently been 
shown that the (3-chain of ATP synthase, a principal protein complex in the mitochondrial 
inner membrane, is also present at the cellular surface and plays a decisive role in the 
regulation of cell homeostasis. As already mentioned, bile acids inhibit the activities of 
complexes I and III of the mitochondrial respiratory chain and may cause cytochrome c 
release and Fas-dependent apoptosis or necrosis. Additionally, bile acids have a direct toxic 
effect on the mitochondria (Krahenbuhl et aL, 1994). 
In our model, exposure to different noxious agents was examined over a relatively 
short time, but long-term effects of NO have to be considered too. GERD is a chronic 
inflammatory disease, which is linked to carcinogenesis. The frequency of adenocarcinoma is 
increased in patients with biliary reflux and chronic inflammation itself can lead to malignant 
transformation (Fein et aL, 2000). Other investigators have suggested that the mechanism of 
the mitogenic effects of bile acids may involve the N-nitrosation of glycine and taurine 
amides, leading to the production of carcinogenic N-nitroso amides (Dayal et aL, 1997). 
Beside its protective effects, excess NO generation is likely to contribute directly to the 
formation of N-nitroso compounds. Thus, the bile-induced overproduction of NO in the long 
run presumably plays a role in the mutagenic process (Bartsch et aL, 1992). 
In the second part of our study, we obtained more data on the pathomechanism of 
biliary esophagitis. The cNOS activity, which was measured in the course of our 
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examinations, involves the activities of two different isoforms: eNOS and nNOS. It has been 
shown that the nNOS activity is responsible for more than 90% of this activity in the 
gastrointestinal tract. Further, the expression of nNOS protein is the highest in the esophagus 
(Fischer et aL, 1999, Qu et aL, 1999). Additional connections between the iNOS and nNOS 
activities were recently described as the function of inducible, Ca2'-independent iNOS is 
closely related to the activation of N F - K B . In the small intestine nNOS suppresses the gene 
expression of iNOS through N F - K B downregulation, while nNOS suppression leads to N F - K B 
activation and iNOS expression (Qu et aL, 2001). These data provided an explanation for our 
results and emphasize the importance of nNOS-derived NO in bile-induced esophageal 
inflammation. 
We presumed that neutrophilic leukocytes are not the only cellular effectors of this 
inflammatory process. The results showed that MCs too are important factors in the 
pathomechanism of inflammation. Mucosal MCs are a unique source of both preformed and 
de novo synthesized mediators, and MC-induced reactions contribute to postischemic mucosal 
permeability alterations and flow responses in the gastrointestinal tract (Szabo et aL, 1997, 
Boros et aL, 2003). Bile acids are able to degranulate MCs both in vitro and in vivo (Rees et 
aL, 1978, Quist et aL, 1991). Moreover, they induce secretion in the small intestine by a 
mechanism involving a histamine-mediated process and MC degranulation (Gelbmann et aL, 
1995, Hardcastle et aL, 2001). It has further been reported that MC-derived histamine is 
involved in esophageal and gastric vasodilation during acid-induced injury (Feldman et aL, 
1996). This type of vasodilation could protect the mucosa against further injury and appears to 
be mediated by calcitonin gene-related peptides (McKie et aL, 1994). Thus, it is reasonable to 
suggest that the bile-induced venodilatory response is closely associated with MC 
degranulation. 
In our study, 7-NI pretreatment significantly amplified the bile-induced tissue damage 
and caused further MC degranulation. 7-NI is an in vivo selective inhibitor of nNOS, because 
it is selectively taken up by cells expressing the nNOS isoform. 7-NI inhibits eNOS only at 
high concentrations (Southan et aL, 1996, Ayajiki et aL, 2001). The residual responses to 7-
NI might be mediated by a previously unblocked part of the nNOS isoform. This also 
suggests that bile principally inhibits eNOS, and the partially sustained nNOS activity is able 
to counteract or at least diminish the harmful effects of bile. It was revealed several years ago 
that NO has an inhibitory action on histamine release from MCs (Masini et aL, 1991, 
Salvemini et aL, 1991,). Thus, the decreased activity of eNOS isoforms may result in the 
degranulation of a high percentage of the esophageal MCs. However, eNOS and nNOS 
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inhibition alone can not explain our results, because the activation of iNOS could probably 
compensate for the absence of cNOS-derived NO. It has been described that MCs in the 
gastrointestinal tract interact directly with nerve cells (Bauer et aL, 2000). As regards the 
high level of expression of nNOS in the esophagus, we can presume the direct role of this 
isoform in the attenuation of MC activation. This underlines the role of nNOS-derived NO in 
the maintenance of esophageal homeostasis. 
In the PC-pretreated animals, the bile-elicited ATP decrease, cNOS inhibiton and MC 
degranulation were significantly attenuated. The question therefore arises as to which process 
may be of critical significance in the mechanism of mucosal protection after PC treatment. PC 
is a ubiquitous membrane-forming entity and the most prominent phospholipid species in the 
gastrointestinal tract. PC is present in high concentration in the bile and constitutes 40% of the 
organic material of bile. In vitro and in vivo experiments have demonstrated that topical PC 
protects the intestinal mucosa physically against the injurious actions of bile salts by forming 
less toxic mixed micelles (Barrios et aL, 2000). Nevertheless, the experimental results and 
clinical experience suggest that PC could function as an active substance under certain in vivo 
conditions. The therapeutic effect of dietary PC in preventing esophageal strictures due to 
alkali-induced esophageal burns has been demonstrated in rats (Demirbilek et aL, 2002), and 
parenteral PC and lyso-PC prolonged survival in experimental sepsis models (Drobnik et aL, 
2003, Yan et aL, 2004). PC is taken up by phagocytic cells and accumulates in inflamed 
tissues (Cleland et aL, 1979). Little is known about the transport of the molecule, but the PC 
transfer protein accelerates the intermembrane transfer of phospholipids in an energy-
independent way. Choline, a metabolite of PC and a precursor of organic osmolyte betaine, is 
actively transported by a choline carrier described in intestinal epithelial and endothelial cells 
of the blood-brain barrier (Friedrich et aL, 2001). 
It is widely believed that the biological efficacy of PC depends on the fatty acid 
moiety (Lieber et aL, 1997). In contrast, some studies have revealed that the protective role of 
PC is independent of fatty acids, and it may be assumed that the active principle is choline. 
Phospholipase-D is activated by almost all stress factors resulting in the release of 
phospholipid metabolites, and several of these factors could be of importance in stress-
induced defense reactions (Exton, 1999). Indeed, it has been shown that PC metabolites 
might relieve a potentially dangerous increase in the ratio of NADH / NAD1" (reductive 
stress), a predisposing cause of oxidative damage (Ghyczy et aL, 2003). This reaction 
sequence could explain the still incompletely understood essential role of choline in diet, and 
its preventive efficacy in a number of experimentally induced pathologies associated with a 
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redox imbalance. It may be assumed that the endogenous pool of these metabolites may 
become exhausted during exogenous provocation and that an exogenous supply might help to 
replenish and strengthen the endogenous protective mechanism. 
In conclusion, our data suggest that the nNOS-MC axis plays an important role in the 
mucosal defense system of the esophagus. Elucidation of the mechanisms by which bile acids 
induce a mucosal dysfunction is complicated by the intrinsic complexity of the esophageal 
tissue, which is made up of many different, but interacting cell types. Whether the findings in 
this experimental model are applicable to humans remains to be established. However, these 
data together with previous observations suggest a therapeutic potential for parenteral PC with 
a view to decreasing the harmful consequences on bile-induced tissue reactions. 
6. SUMMARY AND NEW FINDINGS 
Our in vivo experimental model has provided information on the functional, 
morphological and biochemical changes during the initiation phase of acute esophagitis. The 
investigations have shown that exposure to bile or gastric acid results in local vasodilation, an 
increased capillary flow and leukocyte accumulation. 
• The histological and biochemical findings proved that bile causes a more severe 
mucosal impairment than that due to HC1 alone. 
• Our study has proved that NO and different isoforms of NOS play important roles in 
the pathomechanism of esophagitis. 
• nNOS, as the predominant cNOS isoform in the esophagus, is able to protect the 
esophageal mucosa by preventing the degranulation of mast cells. 
• MC degranulation is involved in the multiplex, noxious effects of bile. 
• Selective inhibition of cNOS exacerbates the tissue damage. 
We presumed that PC might ameliorate bile-induced inflammation. 
• Our results indicate that PC treatment prevents leukocyte accumulation, decreases 
excessive NO production and MC degranulation, and mitigates the bile-induced 
morphological changes. 
These findings reveal the importance of the nNOS-MC axis in the mucosal defense system 
of the esophagus, and additionally that PC may comprise new, prospective therapy for 
biliary esophagitis. 
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